InjuryBoard Houston Archives

• Kugel Mesh Patch

  Lindsay Bauer | January 26, 2007 2:17 PM | 0 Comments
  Category: Defective & Dangerous Products

  Doctors have been advised to stop using the Kugel Mesh Patch and the FDA is recommending that patients who were implanted with Patches on the recall list seek immediate medical attention if they experience unusual symptoms. A hernia is described by doctors as a defect of gap in the abdominal muscle wall through which an intra-abdominal organ can protrude. Weakness or a small tear can cause...

• Bard Composix Kugel Mesh Patch Recall

  Tiffany Farr | January 20, 2007 1:33 PM | 0 Comments
  Category: Defective & Dangerous Products

  On March 31, 2006, the FDA announced a second recall of Davol, Inc.'s Bard Composix Kugel Mesh Patch. The Composix Kugel Mesh Patch is used to repair ventral (incisional) hernias caused by thinning or stretching of scar tissue that forms after surgery. The patch is placed behind the hernia defect through a small incision. The patch is then held open by a "memory recoil ring" that allows the...

• Manufacturer Expands Recall of Composix Kugel Mesh Patches

  John Ghezzi | January 18, 2007 3:20 PM | 0 Comments
  Category: Defective & Dangerous Products

  Davol/Bard and the FDA notified healthcare professionals of an expanded recall and withdrawal of Bard Composix Kugel Large Oval and Large Circle mesh patches. There is a risk that the ring welds could break under stress placed on these products during placement, which could potentially lead to patient complications such as abdominal pain, bowel perforation or chronic enteric fistulas.The...

• Merck Victory as Judge Reduces Next Vioxx Trial

  Allison Snoddy | January 15, 2007 5:02 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Merck has persuaded New Jersey Judge Carol Higbee to reduce the number of cases a jury will hear next from four (4) to two (2) in a victory for Merck. Merck is being sued over the painkiller Vioxx due to claims that it caused heart attacks and strokes. Opening arguments are scheduled to begin January 22, 2006. Merck has vowed that they will try each and every case individually. There are...

• ZYPREXA PAYMENTS ARE ON THE WAY

  Dian Rosier | January 12, 2007 10:54 AM | 0 Comments
  Category: FDA & Prescription Drugs

  The antipsychotic drug, Zyprexa, is commonly used in the treatment of schizophrenia and other psychiatric disorders. Though patients and physicians recognize the drug is highly effective for it's intended purpose, Zyprexa has been found to have a nasty side effect of causing diabetic related injuries in a substantial number of those ingesting the drug.These patients are now facing a life of...

• Expansion of FDA Drug Safety System

  Tracy Beard | January 11, 2007 2:11 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Separately, the FDA is proposing assessing drug companies a fee to review direct-to-consumer television advertisements before they air. The FDA currently has only a limited ability to curb distribution of drug ads that violate federal rules, according to a recent report by government auditors. The FDA expects to collect about $6 million in such fees, which would underwrite the salaries of 27...

• Higher risk of hip fractures in users of heartburn reducers over age fifty

  Christen Wiese | January 08, 2007 5:11 PM | 0 Comments
  Category: FDA & Prescription Drugs

  A large study in Britain has found that using heartburn reducers , such as Nexium, Prilosec and Prevacid, for over a year can increase the risk of hip fractures of people over 50. The researchers theorized that the acid reducing agents make it more difficult to absorb calcium in the body. Therefore weakening bones and making risk of bone fractures higher.Nexiun, Prilosec and Prevacid are in a...